Alphabet from Google, it is the second largest company in S&P 50fter Apple which is followed by Microsoft, Amazon, and Facebook which has a combined value about $3 trillion. It made over a $100 billion gain, the company is trading at just 23 times than expected in 2017 earnings and is growing faster.The big tech companies make it hard to be challenged by others. Amazon is worth $460 billion will be the first to reach $1 trillion.
Adobe, a $4.3 billion TIAA-CREF Large-Cap Growth Fund growth has increased since it moved to cloud subscription model, and the revenue is expected to increase more than 20% this year.Tesla and Uber can displace the traditional car industry by offering great value and performance from its product as technology costs come down.Nvidi.aips is a semiconductor company which is used by Tesla and others f or autonomous driving systems, smartphones, and more.
Stocks to buy in 2017:-
- Google (GOOGL,-0.40%)
- Tesla (TSLA,+6.96%)
- Amazon (AMZN,-0.82%)
- Broadcom (AVGO,-1.40%)
- Adobe (ADBE,-0.25%)
- Nvidia (NVDA, +0.93%)
Six of the 11 S&P 500 industry sectors have their average long-term growth rate. These companies are more huge than the average S&P 500 company carry an average dividend yield of .0 %. A few more listed below will make a great bunch for your portfolio – these are the stocks to buy in 2017.
Abbott Laboratories (ABT)
Abbott Laboratories is a diversified, global healthcare company that secures a place in the list of the stocks to buy in 2017. Its focus is on nutrition, medical products, pharmaceuticals, and diagnostics. Abbott is a unique asset with their “direct-to-consumer” revenue that it generates. Abbott’s stock price recently under-performed due to its concerns about nutritional sales in China and the proposed acquisition of St. Jude. This exposure will be profitable to the clients in the long run.
Becton Dickinson (BDX)
Becton Dickinson is a global supplier of medical devices, hospital supplies, diagnostic equipment, and medication management systems. 85 percent comes from consumer durables and the rest from equipment. The company could benefit from:- an aging population spending more on healthcare[developed nations]; Rising wealth leads to higher healthcare spending with a focus on safety, and moving away from products to towards “solutions.” The company’s earnings did not drop during the 2008/2009 financial crisis, the company’s long-term growth is attractive in the current slow-growth environment. The dividend is 1.7 percent. All these factors make Becton Dickinson secure a spot on the list of the stocks to buy in 2017.
CVS (CVS)
CVS is made of over 9,600 retail pharmacies, over a 1,100 walk-in medical clinics, a pharmacy benefits manager (PBM) with 80 million members, a senior pharmacy care business serving one million patients every year, and an expanding specialty pharmacy business. CVS combined its retail pharmacy business with Caremark’s PBM. The company recently announced that rival PBMs were moving the business away from CVS pharmacies. This resulted in the company reducing the prescriptions filled in 2017, which reduced the revenue and also hit the profits severely. In the long term, CVS is positioned to take advantage of the higher U.S. drug demand (generic, branded and specialty). The PBM business will continue to play an important role in keeping drug costs from rising. It offers a 2.5 % dividend yield. The current valuation appears attractive for long-term investors.
ExxonMobil (XOM)
ExxonMobil an integrated oil company. It starts it business with exploration and production of crude oil and natural gas, then to production of petroleum products, and finally transportation and sale of the crude oil, natural gas and petroleum products. Oil prices are up 50 percent. From the lows of January 2016. ExxonMobil has achieved free cash flow neutrality (cash from operations covers capital expenditure, dividends, and share repurchases). The stock also offers a 3.3 percent dividend yield.
Johnson & Johnson (JNJ)
Johnson & Johnson is the world’s largest and diversified healthcare company. Its revenue is divided among the pharmaceutical, medical device, and consumer divisions. The company should continue to benefit from the aging population and rising standards of living. The company enjoys an AAA-rating on the balance sheet, produces free cash flow, and generates above-average returns on the equity. It has a 2.8 percent dividend yield.All these factors make Johnson & Johnson secure a spot on the list of the stocks to buy in 2017.
Lowe’s (LOW)
The home improvement sector is an attractive area in retail. LOW’s operates a duopoly with competitor Home Depot, while the remaining are small competitors. They also offer immunity from online competition from Amazon.com. These characteristics are rare in the retail sector. Their earnings growth has been very strong in the last few years as solid sales combined with margin expansion has led to producing high-teens EPS growth. Based on positive sales and margin trends, the company will continue to put up double-digit EPS growth for several more years.
Microsoft (MSFT)
Better known for Windows operating system, it is a productivity software powerhouse that has moved to the cloud and a subscription-based revenue model. Azure is Microsoft’s flexible and open enterprise, a cloud computing platform that has become number two to Amazon. Microsoft office and server tools appeal to the commercial enterprises. In 2017 the subscription revenue was large enough to offset the loss of one-time software sales. The stock is trading at 20.7 times estimated CY17 EPS.
Sprouts Farmers Market (SFM)
Shares of Sprouts Farmers Market have suffered due to intense competition and food price deflation. The company operates healthy grocery stores that offer fresh, natural, non-GMO and organic food. The company sits at the crossroads of natural/organic, affordability and accessibility. Their prices are 20 percent-25 percent below traditional supermarkets. Sprouts attract everyday shoppers and the hardcore natural foods customer.
United Technologies (UTX)
United Technologies is a diversified industrial company which provides various products and services to building systems and aerospace industries across the world. Aerospace targets commercials and government. It has a long record of financial performance with double-digit EPS, cash generation, and rock solid balance sheet. The company offers value to long-term investors; the current dividend yield is 2.4%.
